EcoDrugPlus

Mtor Associated Protein, Lst8 Homolog (S. Cerevisiae)

Ensembl ID : ENSIPUG00000002358
Gene Symbol: MLST8
3 Cross references
201 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSIPUG00000002407
Gene Symbol: NAALAD2
3 Cross references
340 Possible Orthologues:

Nad(P)h Dehydrogenase, Quinone 1

Ensembl ID : ENSIPUG00000011403
Gene Symbol: NQO1
2 Cross references
180 Possible Orthologues:

Npc1-Like 1

Ensembl ID : ENSIPUG00000004087
Gene Symbol: NPC1L1
3 Cross references
189 Possible Orthologues:

P2y Purinoceptor 1-Like

Ensembl ID : ENSIPUG00000010789
Gene Symbol: LOC108264770
3 Cross references
190 Possible Orthologues:

P2y Purinoceptor 12

Ensembl ID : ENSIPUG00000004114
Gene Symbol: LOC108280198
3 Cross references
180 Possible Orthologues:

P2y Purinoceptor 3

Ensembl ID : ENSIPUG00000005431
Gene Symbol: LOC108264849
3 Cross references
182 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSIPUG00000011507
Gene Symbol: PTK6B
3 Cross references
159 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSIPUG00000011062
Gene Symbol: PIM1
3 Cross references
246 Possible Orthologues:

Pim-2 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSIPUG00000011752
Gene Symbol: PIM2
3 Cross references
112 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSIPUG00000017494
Gene Symbol: PIM3
4 Cross references
152 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSIPUG00000018733
Gene Symbol: RAF1A
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).